The evidence pyramid is very relevant, because in principle it is what the FDA bases it's approvals on.
Unfortunately for MSB the quality of evidence is from the lowest tier such as that provided to the ODAC panel meeting.
MSB 2022 - The road to commercialisation, page-1330
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.48 |
Change
0.030(2.07%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.50 | $1.47 | $592.4K | 398.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 36716 | $1.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 5586 | 2 |
View Market Depth
| Last trade - 10.14am 14/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |